ARRAY-BRAF (Brain Cancer) - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
Adults with Melanoma that contains the BRAFV600 mutation (that has spread to the brain)
What is Involved?
If you choose to join this study, you will:
- Have a physical
- Have blood tests
- Complete CT and MRI Scans (body scans)
- Take the study drugs (Encorafenib and Binimetinib by mouth in 28 day cycles (up to 2 years)
- Complete follow-up visits every 12 weeks after stopping study drug